申请人:Hoffmann-La Roche Inc.
公开号:US03931288A1
公开(公告)日:1976-01-06
Tricyclic compounds of the formula ##SPC1## Wherein R.sub.1 is hydrogen, halogen, lower alkyl, lower alkoxy, lower alkylthio, trifluoromethyl, cyano, carbamoyl, carboxy, lower alkoxy carbonyl, nitro, amino, mono-lower alkylamino, di-lower alkylamino, acyl, acylamido, sulfamoyl, di-lower alkylsulfamoyl, or difluoromethylsulfonyl; R.sub.2 is hydrogen, lower alkyl, amino-lower alkyl, mono-lower alkyl-amino-lower alkyl, or di-lower alkylamino-lower alkyl; n and r are independently 1 or 2; and X is oxygen or sulfur, prepared, inter alia, from the correspondingly substituted phenol or thiophenol and haloketocyclohexane or pentane carboxylic acid ester, are described. The end products are useful as anti-inflammatory and anti-rheumatic agents.
三环化合物的化学式为##SPC1##,其中R.sub.1是氢、卤素、较低的烷基、较低的烷氧基、较低的烷硫基、三氟甲基、氰基、氨基甲酰、羧基、较低的烷氧羰基、硝基、氨基、单较低的烷基氨基、双较低的烷基氨基、酰基、酰胺基、磺酰胺基、双较低的烷基磺酰胺基或二氟甲基磺酰基;R.sub.2是氢、较低的烷基、氨基较低的烷基、单较低的烷基氨基较低的烷基、或双较低的烷基氨基较低的烷基;n和r独立地为1或2;X是氧或硫。这些化合物可以从相应取代的酚或硫酚和卤代环己烷酮或戊酸酯等物质制备而成。最终产物可用作抗炎和抗风湿药物。